FDA — authorised 1 December 2017
- Application: BLA125521
- Marketing authorisation holder: ELI LILLY AND CO
- Indication: Efficacy
- Status: approved
🇺🇸 Taltz in United States
FDA authorised Taltz on 1 December 2017
Marketing authorisation
Taltz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Taltz approved in United States?
Yes. FDA authorised it on 1 December 2017.
Who is the marketing authorisation holder for Taltz in United States?
ELI LILLY AND CO holds the US marketing authorisation.